Censa Pharmaceuticals
Censa Pharmaceuticals primary focus is the development and commercialization of therapeutics for (ultra) orphan CNS disorders.
Censa Pharmaceuticals is active in the health diagnostics, pharmaceutical, therapeutics space based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2015.
The company sits in the health diagnostics, pharmaceutical, therapeutics segment, where it competes on its core product or service.
The company is recorded as being based in Greater Boston Area, East Coast, New England, Northeastern US.
Its current recorded stage is Series_Unknown.
The company reports a headcount in the c_00001_00010 range.
It has disclosed roughly $1.5M in funding.
| Sector | Health Diagnostics, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2015 |
| Employees | c_00001_00010 |
| Stage | series_unknown |
| Total funding | $1,505,000 |
Website: www.censapharma.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account